Recent news on Dibasic

Lubricant Lifecycle Management - Part 1  -  May 22, 2007
Machinery Lubrication Magaz,Ester-based lubricating oils, including dibasic acid ester, polyol ester and phosphate ester, are the most susceptible to hydrolysis.

Environment protection remains priority  -  May 23, 2007
Global Sources,Ltd manufactures dibasic ester. Deemed nonhazardous, this is a common replacement for methyl ethyl ketone, toluene and methylene chloride or acetone.

Salix Pharmaceuticals Previews Digestive Disease Week 2007  -  May 17, 2007
Genetic Engineering News (press release),Salix also markets OSMOPREP(TM) Tablets (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP), VISICOL(R) Tablets

Salix Pharmaceuticals Announces 1Q2007 Financial Results ...  -  Apr 24, 2007
PharmaLive.com (press release),VISICOL(R) Tablets (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous), PEPCID(R) (famotidine) for Oral Suspension,

Salix Pharmaceuticals Licenses DIACOL™ to Dr. Falk Pharma in Europe  -  Apr 17, 2007
Business Wire (press release),DIACOL, or, sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, tablets, USP, are marketed in the United States under the

Fuji gets DMF for fast dissolving excipient  -  Mar 14, 2007
DrugResearcher.com,...tabletting excipients, Neusilin and Fujicalin. Neusilin is a synthetic magnesium aluminometasilicate and Fujicalin a dibasic calcium phosphate anhydrous.

Salix Pharmaceuticals Reports 4Q2006 and FY2006 Results  -  Feb 28, 2007
Business Wire (press release),OSMOPREP™ Tablets (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) are indicated for cleansing of the colon as a

Market Report -- In Play (SLXP)  -  Dec 13, 2006
MSN MoneyDiacol, or, sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP, was approved March 16, 2006 by the US FDA and is

(China) Cathay Industrial Biotech completes second round financing ...  -  Dec 11, 2006
Biotecheast.com,...will be used in part to improve Cathay's long chain dibasic acids (DC) production technology by replacing the traditional alkane starting raw material,

Cathay Industrial Biotech Ltd. Completes $52 Million Series B ...  -  Dec 6, 2006
American Venture Magazine (press release),The fund raised in the financings will be partially used to improve Cathay’s long chain dibasic acids (DC) production technology by replacing the starting

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional